Leucine-enriched whey protein supplementation, resistance-based exercise, and cardiometabolic health in older adults: a randomized controlled trial.
Authors
Kirk, BenMooney, Kate
Vogrin, Sara
Jackson, Matthew
Duque, Gustavo
Khaiyat, Omid
Amirabdollahian, Farzad
Issue Date
2021-09-14
Metadata
Show full item recordAbstract
Background Increasing protein intake (above the Recommended Dietary Amount) alone or with resistance-based exercise is suggested to improve cardiometabolic health; however, randomized controlled trials (RCTs) are needed to confirm this. Methods The Liverpool Hope University-Sarcopenia Aging Trial (LHU-SAT) was a 16 week RCT (ClinicalTrials.gov Identifier: NCT02912130) of 100 community-dwelling older adults [mean age: 68.73 ± 5.80 years, body mass index: 27.06 ± 5.18 kg/m2 (52% women)] who were randomized to four independent groups [Control (C), Exercise (E), Exercise + Protein (EP), Protein (P)]. E and EP completed supervised and progressive resistance-based exercise (resistance exercise: two times per week, functional circuit exercise: once per week), while EP and P were supplemented with a leucine-enriched whey protein drink (three times per day) based on individual body weight (0.50 g/kg/meal, 1.50 g/kg/day). Outcome measures including arterial stiffness (pulse wave velocity), fasting plasma/serum biomarkers [glucose/glycated haemoglobin, total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein, insulin, resistin, leptin, adiponectin, C-reactive protein, tumour necrosis factor-alpha, interleukin-6, cystatin-C, & ferritin], insulin resistance (HOMA-IR), and kidney function (eGFR) were measured before and after intervention. Results Total protein intake (habitual diet plus supplementation) increased to 1.55 ± 0.69 g/kg/day in EP and to 1.93 ± 0.72 g/kg/day in P, and remained significantly lower (P < 0.001) in unsupplemented groups (E: 1.08 ± 0.33 g/kg/day, C: 1.00 ± 0.26 g/kg/day). At 16 weeks, there was a group-by-time interaction whereby absolute changes in LDL-cholesterol were lower in EP [mean difference: −0.79 mmol/L, 95% confidence interval (CI): −1.29, −0.28, P = 0.002] and P (mean difference: −0.76 mmol/L, 95% CI: −1.26, −0.26, P = 0.003) vs. C. Serum insulin also showed group-by-time interactions at 16 weeks whereby fold changes were lower in EP (mean difference: −0.40, 95% CI: −0.65, −0.16, P = 0.001) and P (mean difference: −0.32, 95% CI: −0.56, −0.08, P = 0.009) vs. C, and fold changes in HOMA-IR improved in EP (mean difference: −0.37, 95% CI: −0.64, −0.10, P = 0.007) and P (mean difference: −0.27, 95% CI: −0.53, −0.00, P = 0.048) vs. C. Serum resistin declined in P only (group-by-time interaction at 16 weeks: P = 0.009). No other interactions were observed in outcome measures (P > 0.05), and kidney function (eGFR) remained unaltered. Conclusions Sixteen weeks of leucine-enriched whey protein supplementation alone and combined with resistance-based exercise improved cardiometabolic health markers in older adults.Citation
Kirk, B., Mooney, K., Vogrin, S., Jackson, M., Duque, G., et al. (2021) Leucine-enriched whey protein supplementation, resistance-based exercise, and cardiometabolic health in older adults: a randomized controlled trial, Journal of Cachexia, Sarcopenia and Muscle, 12 (6), pp. 2022– 2033, https://doi.org/10.1002/jcsm.12805Publisher
WileyJournal
Journal of cachexia, sarcopenia and musclePubMed ID
34520104 (pubmed)Additional Links
https://onlinelibrary.wiley.com/doi/10.1002/jcsm.12805Type
Journal articleLanguage
enDescription
© 2021 The Authors. Published by Wiley. This is an open access article available under a Creative Commons licence. The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.1002/jcsm.12805ISSN
2190-5991EISSN
2190-6009Sponsors
This work was supported by internal doctoral research scholarships (awarded to B.K. and K.M. during 2016–2019) from Liverpool Hope University who purchased the protein supplements directly from the manufacture (MyProtein, UK) at retail price with no discount applied. No external funding was received for this study.ae974a485f413a2113503eed53cd6c53
10.1002/jcsm.12805
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Licence for published version: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Related articles
- Leucine-enriched whey protein supplementation, resistance-based exercise, and cardiometabolic health in older adults: a randomized controlled trial.
- Authors: Kirk B, Mooney K, Vogrin S, Jackson M, Duque G, Khaiyat O, Amirabdollahian F
- Issue date: 2021 Dec
- Exercise and Dietary-Protein as a Countermeasure to Skeletal Muscle Weakness: Liverpool Hope University - Sarcopenia Aging Trial (LHU-SAT).
- Authors: Kirk B, Mooney K, Amirabdollahian F, Khaiyat O
- Issue date: 2019
- Effects of exercise and whey protein on muscle mass, fat mass, myoelectrical muscle fatigue and health-related quality of life in older adults: a secondary analysis of the Liverpool Hope University-Sarcopenia Ageing Trial (LHU-SAT).
- Authors: Kirk B, Mooney K, Cousins R, Angell P, Jackson M, Pugh JN, Coyles G, Amirabdollahian F, Khaiyat O
- Issue date: 2020 Feb
- Effects of whey protein plus vitamin D supplementation combined with progressive resistance training on glycaemic control, body composition, muscle function and cardiometabolic risk factors in middle-aged and older overweight/obese adults with type 2 diabetes: A 24-week randomized controlled trial.
- Authors: Miller EG, Nowson CA, Dunstan DW, Kerr DA, Menzies D, Daly RM
- Issue date: 2021 Apr